15年以上：经导管主动脉瓣置换术的进展
Over 15 years: the advancement of transcatheter aortic valve replacement.
作者信息
Cahill Thomas J, Terre Juan A, George Isaac
机构信息
Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, NY, USA.
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
出版信息
Ann Cardiothorac Surg. 2020 Nov;9(6):442-451. doi: 10.21037/acs-2020-av-24.
Abstract
The management of aortic stenosis has been revolutionized by transcatheter aortic valve replacement (TAVR). Initially only undertaken in patients at prohibitive or high surgical risk, as the evidence base and indications have expanded, TAVR is now approved and undertaken in patients at all risk levels. Evolution of valve technology, delivery systems and pathways for patient work-up have been rapid, with associated reductions in the complication profile, particularly vascular complications. Challenges remain as TAVR continues to advance, however, specifically achieving further reduction in paravalvular regurgitation, the requirement for permanent pacemaker implantation, and balancing the risks of thrombosis and bleeding. In this review, we outline the historical advances leading to contemporary TAVR practice, and discuss the future trajectory.
摘要
经导管主动脉瓣置换术（TAVR）彻底改变了主动脉瓣狭窄的治疗方式。最初，该手术仅针对手术风险极高或无法进行手术的患者进行，随着证据基础的扩大和适应症的增加，如今TAVR已获批用于所有风险级别的患者。瓣膜技术、输送系统以及患者术前检查流程都在迅速发展，并发症发生率，尤其是血管并发症有所降低。然而，随着TAVR的不断发展，挑战依然存在，特别是如何进一步减少瓣周反流、永久起搏器植入的需求，以及平衡血栓形成和出血的风险。在本综述中，我们概述了促成当代TAVR实践的历史进展，并讨论了未来的发展轨迹。
相似文献
1
Over 15 years: the advancement of transcatheter aortic valve replacement.15年以上：经导管主动脉瓣置换术的进展
Ann Cardiothorac Surg. 2020 Nov;9(6):442-451. doi: 10.21037/acs-2020-av-24.
2
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.经导管主动脉瓣置换术与外科主动脉瓣置换术在低危患者中的比较。
J Am Coll Cardiol. 2019 Sep 24;74(12):1532-1540. doi: 10.1016/j.jacc.2019.06.076.
3
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis.经导管主动脉瓣置换术治疗有症状的低危重度主动脉瓣狭窄患者。
J Am Coll Cardiol. 2018 Oct 30;72(18):2095-2105. doi: 10.1016/j.jacc.2018.08.1033. Epub 2018 Aug 28.
4
Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations.经导管主动脉瓣置换术：结果、适应症、并发症及创新
Curr Treat Options Cardiovasc Med. 2017 Sep 22;19(10):81. doi: 10.1007/s11936-017-0580-0.
5
Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.经导管主动脉瓣置换术与外科主动脉瓣置换术治疗中危重度主动脉瓣狭窄患者的成本效果分析。
Circulation. 2019 Feb 12;139(7):877-888. doi: 10.1161/CIRCULATIONAHA.118.035236.
6
Meta-Analysis of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis.严重主动脉瓣狭窄患者经导管主动脉瓣置换术与外科主动脉瓣置换术的Meta分析
Am J Cardiol. 2016 Jan 15;117(2):252-7. doi: 10.1016/j.amjcard.2015.10.034. Epub 2015 Nov 6.
7
Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.高危手术患者中经导管主动脉瓣自膨胀置换术与外科瓣膜置换术的比较：一项关于超声心动图变化及风险预测的研究
Circ Cardiovasc Interv. 2016 Jun;9(6). doi: 10.1161/CIRCINTERVENTIONS.115.003426.
8
Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).经导管主动脉瓣置换术与外科主动脉瓣置换术后出血并发症比较：来自 PARTNER I 试验（经导管主动脉瓣置入术）的见解。
J Am Coll Cardiol. 2014 Mar 25;63(11):1100-9. doi: 10.1016/j.jacc.2013.10.058. Epub 2013 Nov 27.
9
Ten-year experience with transcatheter and surgical aortic valve replacement in Finland.芬兰经导管主动脉瓣置换术和外科主动脉瓣置换术的 10 年经验。
Ann Med. 2019 May-Jun;51(3-4):270-279. doi: 10.1080/07853890.2019.1614657. Epub 2019 May 21.
10
Comparison of Short and Mid-Term Mortality and Morbidity in Patients With Severe Aortic Stenosis (Intermediate/High Risk) Who Underwent Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement.对比行经导管主动脉瓣置换术与外科主动脉瓣置换术的严重主动脉瓣狭窄（中危/高危）患者的短期及中期死亡率和发病率。
Heart Surg Forum. 2020 Apr 15;23(2):E212-E220. doi: 10.1532/hsf.2913.
引用本文的文献
1
Long-Term Outcome of Covered Stent Implantation for Management of Iliofemoral Vascular Complications in Patients Undergoing Transcatheter Aortic Valve Replacement.覆膜支架植入术治疗经导管主动脉瓣置换术患者髂股血管并发症的长期预后
Struct Heart. 2025 May 13;9(9):100489. doi: 10.1016/j.shj.2025.100489. eCollection 2025 Sep.
2
Current hotspot and study trend of transcatheter aortic valve replacement, a bibliometric analysis from 2009 to 2023.经导管主动脉瓣置换术的当前热点与研究趋势：一项2009年至2023年的文献计量分析
Front Cardiovasc Med. 2025 Apr 14;12:1411561. doi: 10.3389/fcvm.2025.1411561. eCollection 2025.
3
Emerging Transcatheter Therapies for Valvular Heart Disease: Focus on Mitral and Tricuspid Valve Procedures.用于心脏瓣膜病的新兴经导管治疗：聚焦二尖瓣和三尖瓣手术
Life (Basel). 2024 Jul 2;14(7):842. doi: 10.3390/life14070842.
4
Transcatheter aortic valve replacement in the management of aortic insufficiency secondary to left ventricular assist device implantation: a case report.经导管主动脉瓣置换术治疗左心室辅助装置植入术后继发的主动脉瓣关闭不全：一例报告
J Thorac Dis. 2023 Dec 30;15(12):7130-7139. doi: 10.21037/jtd-23-1642. Epub 2023 Dec 26.
5
Comparative Analysis of TAVR (Transcatheter Aortic Valve Replacement) and Surgical Valve Replacement for Low-Risk Patients.低风险患者经导管主动脉瓣置换术（TAVR）与外科瓣膜置换术的对比分析
Cureus. 2023 Oct 17;15(10):e47234. doi: 10.7759/cureus.47234. eCollection 2023 Oct.
6
Drivers and outcomes of variation in surgical versus transcatheter aortic valve replacement in Ontario, Canada: a population-based study.加拿大安大略省经导管主动脉瓣置换术与外科主动脉瓣置换术的差异的驱动因素和结果：一项基于人群的研究。
Open Heart. 2022 Jan;9(1). doi: 10.1136/openhrt-2021-001881.
本文引用的文献
1
Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.PARTNER-2 试验中经导管主动脉瓣与外科主动脉瓣生物假体的结构性衰退。
J Am Coll Cardiol. 2020 Oct 20;76(16):1830-1843. doi: 10.1016/j.jacc.2020.08.049.
2
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.经导管主动脉瓣置换术后阿司匹林联合或不联合氯吡格雷
N Engl J Med. 2020 Oct 8;383(15):1447-1457. doi: 10.1056/NEJMoa2017815. Epub 2020 Aug 30.
3
Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.经导管主动脉瓣置换术后联合或不联合氯吡格雷的抗凝治疗。
N Engl J Med. 2020 Apr 30;382(18):1696-1707. doi: 10.1056/NEJMoa1915152. Epub 2020 Mar 29.
4
Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial.经导管主动脉瓣植入术中新一代自膨胀式瓣膜与球囊扩张式瓣膜的比较：随机SOLVE-TAVI试验
Eur Heart J. 2020 May 21;41(20):1890-1899. doi: 10.1093/eurheartj/ehaa036.
5
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.经导管主动脉瓣置换术患者传导障碍的临床影响：一项系统评价和荟萃分析。
Eur Heart J. 2020 Aug 1;41(29):2771-2781. doi: 10.1093/eurheartj/ehz924.
6
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.经导管主动脉瓣置换术后利伐沙班的对照试验。
N Engl J Med. 2020 Jan 9;382(2):120-129. doi: 10.1056/NEJMoa1911425. Epub 2019 Nov 16.
7
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.经导管主动脉瓣置换术后新发左束支传导阻滞与中危患者不良长期临床结局相关：来自 PARTNER II 试验的分析。
Eur Heart J. 2019 Jul 14;40(27):2218-2227. doi: 10.1093/eurheartj/ehz227.
8
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.经导管主动脉瓣植入术与外科主动脉瓣置换术治疗症状性重度主动脉瓣狭窄的比较：一项更新的荟萃分析。
Eur Heart J. 2019 Oct 7;40(38):3143-3153. doi: 10.1093/eurheartj/ehz275.
9
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.经皮球囊扩张式主动脉瓣置换术治疗低危患者。
N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16.
10
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.经导管主动脉瓣置换术治疗低危患者的自膨式瓣膜。
N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16.
Zotero 插件